Growing community of inventors

Guangdong, China

Dongya Zhang

Average Co-Inventor Count = 5.22

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Dongya ZhangQiang Feng (3 patents)Dongya ZhangJun Wang (2 patents)Dongya ZhangJun Wang (1 patent)Dongya ZhangJian Wang (1 patent)Dongya ZhangDonghui Wang (1 patent)Dongya ZhangHuanming Yang (1 patent)Dongya ZhangLongqing Tang (1 patent)Dongya ZhangGuang Ning (4 patents)Dongya ZhangWeiqing Wang (3 patents)Dongya ZhangHuijue Jia (1 patent)Dongya ZhangZhuye Jie (1 patent)Dongya ZhangJunjie Qin (1 patent)Dongya ZhangRuixin Liu (2 patents)Dongya ZhangXiaoqiang Xu (2 patents)Dongya ZhangShenghui Li (1 patent)Dongya ZhangXiaokai Wang (0 patent)Dongya ZhangYanyun Gu (0 patent)Dongya ZhangJun Wang (1 patent)Dongya ZhangDongya Zhang (3 patents)Qiang FengQiang Feng (13 patents)Jun WangJun Wang (36 patents)Jun WangJun Wang (225 patents)Jian WangJian Wang (70 patents)Donghui WangDonghui Wang (31 patents)Huanming YangHuanming Yang (8 patents)Longqing TangLongqing Tang (6 patents)Guang NingGuang Ning (4 patents)Weiqing WangWeiqing Wang (3 patents)Huijue JiaHuijue Jia (3 patents)Zhuye JieZhuye Jie (3 patents)Junjie QinJunjie Qin (3 patents)Ruixin LiuRuixin Liu (2 patents)Xiaoqiang XuXiaoqiang Xu (2 patents)Shenghui LiShenghui Li (1 patent)Xiaokai WangXiaokai Wang (0 patent)Yanyun GuYanyun Gu (0 patent)Jun WangJun Wang (30 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Bgi Shenzhen (3 from 49 patents)

2. Bgi-shenzhen Co., Limited (2 from 14 patents)

3. Shanghai Institute for Endocrine and Metabolic Diseases (0 patent)


3 patents:

1. 10883146 - Biomarkers for rheumatoid arthritis and usage thereof

2. 10526659 - Biomarkers for colorectal cancer

3. 10100360 - Biomarkers for diabetes and usages thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/1/2026
Loading…